Fifth Third Bancorp
RARE icon

Fifth Third Bancorp’s Ultragenyx Pharmaceutical RARE Stock Holding History

Fifth Third Bancorp’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.31M Buy
+110,272
New +$2.48M ﹤0.01% 1144
2019
Q1 		– Sell
-1
Closed – – 2279
2018
Q4 		$0 Sell
1
-126
-99% -$6.89K ﹤0.01% 2325
2018
Q3 		$10K Sell
127
-111
-47% -$9.03K ﹤0.01% 1833
2018
Q2 		$18K Hold
238
– – ﹤0.01% 1697
2018
Q1 		$12K Hold
238
– – ﹤0.01% 1845
2017
Q4 		$11K Sell
238
-813
-77% -$39.9K ﹤0.01% 1802
2017
Q3 		$56K Sell
1,051
-196
-16% -$11.6K ﹤0.01% 1257
2017
Q2 		$77K Buy
1,247
+1,178
+1,707% +$71K ﹤0.01% 1148
2017
Q1 		$5K Sell
69
-735
-91% -$56K ﹤0.01% 1852
2016
Q4 		$57K Sell
804
-618
-43% -$43.8K ﹤0.01% 1290
2016
Q3 		$101K Buy
1,422
+173
+14% +$11K ﹤0.01% 1101
2016
Q2 		$61K Sell
1,249
-111
-8% -$7.18K ﹤0.01% 1225
2016
Q1 		$86K Buy
+1,360
New +$89K ﹤0.01% 1140
2015
Q4 		– Sell
-7
Closed -$1K – 2851
2015
Q3 		$1K Buy
+7
New +$801 ﹤0.01% 2775

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Fifth Third Bancorp's RARE Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in Ultragenyx Pharmaceutical (RARE) in Q1 2026: 110,272 shares worth $2.31M. The stake represents ﹤0.01% of the portfolio and ranks #1144 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in RARE as recently as Q4 2018.

Fifth Third Bancorp first reported a position in RARE in Q3 2015 and has held it in 14 quarters since. 296 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Fifth Third Bancorp held 110,272 shares of Ultragenyx Pharmaceutical worth $2.31M as of Q1 2026.
  • Ultragenyx Pharmaceutical was a new Fifth Third Bancorp position in Q1 2026.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #1144 holding.
  • Fifth Third Bancorp first reported a position in Ultragenyx Pharmaceutical in Q3 2015 and has held it in 14 quarters since.
  • 296 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.